SUBSEQUENT EVENTS (Details)	6 Months Ended			6 Months Ended	12 Months Ended	0 Months Ended							1 Months Ended		0 Months Ended		0 Months Ended	1 Months Ended	0 Months Ended		0 Months Ended			0 Months Ended
	Jun. 30, 2014 USD ($)	Jun. 30, 2013 USD ($)	Dec. 31, 2013 USD ($)	Jun. 30, 2014 Stock Option USD ($)	Dec. 31, 2013 Stock Option	May 01, 2014 Employment contract	Jun. 30, 2014 Convertible promissory notes USD ($)	Nov. 06, 2013 Convertible promissory notes USD ($)	Jun. 30, 2014 Convertible promissory notes Sonkei USD ($)	Jun. 30, 2014 Convertible promissory notes Sonkei EUR (€)	Nov. 12, 2013 Convertible promissory notes Sonkei USD ($)	Nov. 12, 2013 Convertible promissory notes Sonkei EUR (€)	Jul. 31, 2014 Subsequent event Employment contract Stock Option USD ($)	Jul. 31, 2014 Subsequent event Loans payable USD ($)	Jul. 07, 2014 Subsequent event Convertible promissory notes	Jul. 07, 2014 Subsequent event Convertible promissory notes USD ($)	Jul. 07, 2014 Subsequent event Co-development licensor Common stock purchase agreement USD ($)	Jul. 31, 2014 Subsequent event Co-development licensor Co-development and license agreement MIN-202 USD ($)	Jul. 07, 2014 Subsequent event IPO USD ($)	Jul. 07, 2014 Subsequent event IPO USD ($)	Jul. 07, 2014 Subsequent event IPO ProteoSys USD ($)	Jul. 07, 2014 Subsequent event Private placement USD ($)	Jul. 07, 2014 Subsequent event Private placement USD ($)	Jul. 29, 2014 Subsequent event Over-allotment USD ($)	Jul. 29, 2014 Subsequent event Over-allotment USD ($)
Subsequent events
Sale of common stock (in shares)																	3,284,353		5,454,545			666,666		160,993
Share price (in dollars per share)																$ 6.00				$ 6.00			$ 6.00		$ 6.00
Aggregate proceeds from sale of common stock																			$ 32,700,000			$ 4,000,000
Net proceeds from sale of common stock		1,850,000															19,700,000		25,200,000			3,700,000		900,000
Underwriting discount																			2,300,000			300,000		100,000
Stock issuance expenses	105,417																		3,100,000
Repayment of the bridge loans	500,000													1,400,000
Payments of License Fees																		22,000,000			700,000
Interest rate (as a percent)								8.00%			8.00%	8.00%
Face amount							1,300,000	1,300,000	700,000	518,519	680,000	518,519
Accrued interest	$ 114,429		$ 24,276				$ 67,000		$ 35,000							$ 100,000
Common stock issued upon conversion (in shares)															352,000
Number of common shares to be issued for options granted				1,495,048	646,759								366,562
Exercise price of options granted (in dollars per share)				$ 5.11									$ 6.00
Vesting period						4 years							4 years